National Pension Service increased its position in shares of Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 691,606 shares of the company’s stock after buying an additional 63,399 shares during the period. National Pension Service owned 0.21% of Kimberly-Clark worth $75,918,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in shares of Kimberly-Clark in the second quarter valued at about $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of Kimberly-Clark during the fourth quarter worth $25,000. CrossGen Wealth LLC bought a new position in shares of Kimberly-Clark in the 4th quarter valued at $27,000. Ancora Advisors LLC bought a new position in shares of Kimberly-Clark in the 2nd quarter valued at $32,000. Finally, Edmond DE Rothschild Holding S.A. bought a new position in Kimberly-Clark in the second quarter valued at about $32,000. 76.29% of the stock is owned by institutional investors and hedge funds.
Kimberly-Clark Price Performance
Kimberly-Clark stock opened at $98.15 on Friday. The stock’s 50 day moving average is $108.69 and its 200 day moving average is $103.44. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.91 and a quick ratio of 0.69. The firm has a market cap of $32.64 billion, a P/E ratio of 16.69, a P/E/G ratio of 4.12 and a beta of 0.25. Kimberly-Clark Corporation has a one year low of $92.42 and a one year high of $129.87.
Kimberly-Clark Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 2nd. Stockholders of record on Friday, September 4th will be given a dividend of $1.28 per share. The ex-dividend date is Friday, September 4th. This represents a $5.12 annualized dividend and a dividend yield of 5.2%. Kimberly-Clark’s dividend payout ratio is 87.07%.
Analysts Set New Price Targets
A number of brokerages have recently commented on KMB. Freedom Capital raised Kimberly-Clark from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 4th. Piper Sandler dropped their price objective on shares of Kimberly-Clark from $121.00 to $118.00 and set an “overweight” rating for the company in a report on Friday. UBS Group boosted their target price on shares of Kimberly-Clark from $115.00 to $116.00 and gave the stock a “neutral” rating in a report on Wednesday, August 5th. TD Cowen upped their price target on shares of Kimberly-Clark from $96.00 to $104.00 and gave the company a “hold” rating in a research report on Wednesday, August 5th. Finally, Seaport Research Partners raised shares of Kimberly-Clark to a “buy” rating in a research note on Tuesday, August 4th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Kimberly-Clark currently has an average rating of “Hold” and a consensus target price of $117.36.
Check Out Our Latest Research Report on KMB
Kimberly-Clark Profile
Kimberly-Clark Corporation is a global manufacturer of personal care and consumer tissue products. The company develops and markets products designed to support personal hygiene, health and well-being in households, healthcare settings and workplaces.
Its portfolio includes well-known brands such as Huggies diapers and training pants, Kleenex facial tissues, Cottonelle toilet paper and wipes, Scott toilet paper and paper towels, Kotex feminine care products, and Depend and Poise incontinence care products.
Recommended Stories
- Five stocks we like better than Kimberly-Clark
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
